CUAMC
APGE icon

China Universal Asset Management Company’s Apogee Therapeutics APGE Stock Holding History

China Universal Asset Management Company’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
9,852
+121
+1% +$10.9K 0.08% 181
2026
Q1 		$819K Buy
9,731
+796
+9% +$57.8K 0.06% 214
2025
Q4 		$674K Buy
8,935
+853
+11% +$53.7K 0.05% 228
2025
Q3 		$321K Sell
8,082
-6,166
-43% -$235K 0.03% 286
2025
Q2 		$619K Buy
14,248
+5,216
+58% +$198K 0.06% 225
2025
Q1 		$337K Sell
9,032
-515
-5% -$19.9K 0.03% 275
2024
Q4 		$432K Buy
9,547
+892
+10% +$45.5K 0.04% 263
2024
Q3 		$508K Buy
8,655
+3,371
+64% +$162K 0.06% 216
2024
Q2 		$208K Sell
5,284
-1,871
-26% -$90.8K 0.03% 238
2024
Q1 		$475K Buy
7,155
+1,600
+29% +$69.9K 0.06% 185
2023
Q4 		$155K Buy
+5,555
New +$111K 0.03% 232

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

China Universal Asset Management Company's APGE Position: Q2 2026 in Review

China Universal Asset Management Company increased its Apogee Therapeutics (APGE) stake by 1.2% in Q2 2026, buying an estimated $10.9K and bringing the position to 9,852 shares worth $1.31M. The position accounts for 0.08% of the portfolio, ranked #181.

China Universal Asset Management Company first reported a position in APGE in Q4 2023 and has held it in 11 quarters since. 288 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • China Universal Asset Management Company held 9,852 shares of Apogee Therapeutics worth $1.31M as of Q2 2026.
  • China Universal Asset Management Company bought 121 Apogee Therapeutics shares in Q2 2026, an estimated $10.9K.
  • Apogee Therapeutics made up 0.08% of China Universal Asset Management Company's portfolio in Q2 2026, its #181 holding.
  • China Universal Asset Management Company first reported a position in Apogee Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 288 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.